George Kitas | rheumatology.medicinematters.com
Skip to main content
Menu
Home
Latest news
Browse topics
Chevron down icon
Chevron up icon
Lupus
Rheumatoid arthritis
Spondyloarthropathies
COVID-19
Browse all topics
In focus
Chevron down icon
Chevron up icon
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences
Chevron down icon
Chevron up icon
ACR Convergence 2022
EULAR 2022 Congress
About us
Medicine Matters Rheumatology
Medicine Matters Rheumatology
Search
Search icon
EXTENDED SEARCH
Medicine Matters Rheumatology
George Kitas
Contact
address:
Dudley Group NHS Foundation Trust
print
PRINT